Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study.

Autor: Osuga Y; Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: yutakaostky@gmail.com., Kobayashi T; Department of Obstetrics and Gynecology, Hamamatsu Medical Center, Hamamatsu, Japan., Hirakawa A; Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Takayanagi T; Department of Clinical Development, Fuji Pharma Co., Ltd., Tokyo, Japan., Nogami M; Department of Clinical Development, Fuji Pharma Co., Ltd., Tokyo, Japan., Tayzar K; Department of Clinical Development, Fuji Pharma Co., Ltd., Tokyo, Japan., Mochiyama T; Department of Clinical Development, Fuji Pharma Co., Ltd., Tokyo, Japan., Hirayama M; Department of Clinical Development, Fuji Pharma Co., Ltd., Tokyo, Japan., Foidart JM; Department of Obstetrics and Gynecology, University of Liège, 4000 Liège, Belgium., Harada T; Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Japan.

Publikováno v: Fertility and sterility [Fertil Steril] 2024 Nov 07. Date of Electronic Publication: 2024 Nov 07.